To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

INTRODUCTION: Triple artemisinin-based combination therapies (TACTs) are being developed as a response to artemisinin and partner drug resistance in the treatment of falciparum malaria in Southeast Asia. In African countries, where current artemisinin-based combination therapies (ACTs) are still eff...

Descripción completa

Detalles Bibliográficos
Autores principales: de Haan, Freek, Bolarinwa, Oladimeji Akeem, Guissou, Rosemonde, Tou, Fatoumata, Tindana, Paulina, Boon, Wouter P. C., Moors, Ellen H. M., Cheah, Phaik Yeong, Dhorda, Mehul, Dondorp, Arjen M., Ouedraogo, Jean Bosco, Mokuolu, Olugbenga A., Amaratunga, Chanaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407563/
https://www.ncbi.nlm.nih.gov/pubmed/34464398
http://dx.doi.org/10.1371/journal.pone.0256567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407563/
https://www.ncbi.nlm.nih.gov/pubmed/34464398
http://dx.doi.org/10.1371/journal.pone.0256567

Ejemplares similares